Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study Walter AgenoIvan B. CasellaSamuel Z. Goldhaber OriginalPaper Open access 26 August 2020 Pages: 561 - 570
Evidence of systemic endothelial injury and microthrombosis in hospitalized COVID-19 patients at different stages of the disease Domenico G. Della RoccaMichele MagnocavalloAndrea Natale Report 06 November 2020 Pages: 571 - 576
Platinoid effects on human plasmatic coagulation kinetics: a viscoelastic analysis Vance G. Nielsen OriginalPaper 02 January 2021 Pages: 577 - 583
Association of ABO blood group type with cardiovascular events in COVID-19 Victor NauffalAditya AchantaGregory Piazza Report 15 January 2021 Pages: 584 - 586
COVID-19 and its sequelae: a platform for optimal patient care, discovery and training Richard C. Becker Editorial 27 January 2021 Pages: 587 - 594
Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review William J. JennerRahim KanjiDiana A. Gorog ReviewPaper Open access 14 February 2021 Pages: 595 - 607
Immature platelets in patients hospitalized with Covid-19 Amir CohenEmanuel HarariEli I. Lev OriginalPaper 30 September 2020 Pages: 608 - 616
Evaluation of relationship between KEAP1 gene and genetic susceptibility of deep vein thrombosis after orthopedic surgery in Han Chinese population Wei HuangQiang ChenLiqiang Zhi OriginalPaper 07 August 2020 Pages: 617 - 624
MRP4 over-expression has a role on both reducing nitric oxide-dependent antiplatelet effect and enhancing ADP induced platelet activation Maria Luisa GuarinoIsabella MassimiFabio M. Pulcinelli OriginalPaper Open access 14 August 2020 Pages: 625 - 632
Can fibrinolytic therapy be clinically useful in severe pneumonia caused by COVID-19? Rafael BornsteinJosé Antonio Páramo ReviewPaper 12 August 2020 Pages: 633 - 636
High prevalence of early asymptomatic venous thromboembolism in anticoagulated COVID-19 patients hospitalized in general wards Sylvain Le JeuneJaehyo SuhlRobin Dhote BriefCommunication 18 August 2020 Pages: 637 - 641
Anticoagulant treatment in COVID-19: a narrative review Vincenzo CarforaGiorgio SpinielloVanvitelli COVID-19 group ReviewPaper Open access 18 August 2020 Pages: 642 - 648
Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate Itsuki OsawaKoh OkamotoKyoji Moriya OriginalPaper 12 September 2020 Pages: 649 - 656
Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19 Xin WangKamal Kant SahuJan Cerny ReviewPaper 15 October 2020 Pages: 657 - 662
COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis Bingwen Eugene FanJensen NgYew Woon Chia OriginalPaper 24 October 2020 Pages: 663 - 674
Biomarkers of platelet activation and cardiovascular risk in the DAPT trial David D. BergRobert W. YehMichelle L. O’Donoghue OriginalPaper 18 July 2020 Pages: 675 - 681
Clinical outcomes after percutaneous coronary intervention for early versus late and very late stent thrombosis: a systematic review and meta-analysis Yi-Xing YangYin LiuJing Gao OriginalPaper Open access 20 July 2020 Pages: 682 - 692
Effects of clinical depression on left ventricular dysfunction in patients with acute coronary syndrome Jacob SamaDhananjay VaidyaMarlene Williams OriginalPaper 02 September 2020 Pages: 693 - 700
Direct oral anticoagulants are effective and safe in the treatment of venous thromboembolism and atrial fibrillation in morbidly obese patients Mouhand F. H. MohamedHazem ElewaMohammed Danjuma Letter to the Editor 31 July 2020 Pages: 701 - 702
Platelet count trends and response to fondaparinux in a cohort of heparin-induced thrombocytopenia suspected patients after pulmonary endarterectomy Ji-Feng LiLi-Juan WuYuan-Hua Yang OriginalPaper 07 September 2020 Pages: 703 - 710
A pilot study of procoagulant platelet extracellular vesicles and P-selectin increase during induction treatment in acute lymphoblastic leukaemia paediatric patients: two new biomarkers of thrombogenic risk? Claire PluchartCoralie BarbePhilippe Nguyen OriginalPaper 28 November 2020 Pages: 711 - 719
Thromboprophylaxis for patients with newly diagnosed vs. recurrent cancers: a post-hoc analysis of the avert trial James ZhangMarina AtallaMarc Carrier OriginalPaper 20 October 2020 Pages: 720 - 724
Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series Chieh Min Benjamin LaiTyler SmithAgnes Yuet Ying Lee OriginalPaper 13 February 2021 Pages: 725 - 733
The clinical characteristic, diagnosis, treatment, and prognosis of cerebral cortical vein thrombosis: a systematic review of 325 cases Si-ying SongDuo LanRan Meng ReviewPaper 31 July 2020 Pages: 734 - 740
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor Dominick J. AngiolilloLatonya BeenFrancesco Franchi OriginalPaper Open access 13 February 2021 Pages: 741 - 747
Decreased pulmonary artery distensibility as a marker for severity in acute pulmonary embolism patients undergoing ECG-gated CTPA Fei YangDawei WangQingxiao Liu OriginalPaper 18 March 2021 Pages: 748 - 756
The perplexity of catheter-directed thrombolysis for deep venous thrombosis: the approaches play an important role Chengheng QianGuo-ping ChenYing-hao Li OriginalPaper 14 July 2020 Pages: 757 - 766
Factors influencing cognitive performance after 1-year treatment with direct oral anticoagulant in patients with atrial fibrillation and previous ischemic stroke: a pilot study Manuel CappellariStefano ForlivesiPaolo Bovi OriginalPaper 29 July 2020 Pages: 767 - 778
Clinical characteristics and outcomes of patients with venous thromboembolism according to diagnosis on weekends versus on weekdays Yugo YamashitaTakeshi Morimotoon behalf of the COMMAND VTE Registry Investigators OriginalPaper 29 July 2020 Pages: 779 - 788
Stress hyperglycemia is predictive of worse outcome in patients with acute ischemic stroke undergoing intravenous thrombolysis Giovanni MerlinoCarmelo SmeraldaMariarosaria Valente OriginalPaper 24 August 2020 Pages: 789 - 797
Characteristics and risk factors of deep vein thrombosis in hemiplegic, healthy and bilateral limbs of hemiplegic patients: a 10-year retrospective study Feng LiangMin ChaoXiang-Ming Ye OriginalPaper 27 August 2020 Pages: 798 - 804
Rescue catheter-based therapies for the treatment of acute massive pulmonary embolism after unsuccessful systemic thrombolysis Maofeng GongGuoping ChenXu He OriginalPaper 19 August 2020 Pages: 805 - 813
Utility of the 4Ts score in excluding heparin-induced thrombocytopenia in lung transplant recipients Sara WuMaureen P. ConverseTara M. Veasey BriefCommunication 20 August 2020 Pages: 814 - 817
Excessive fibrinolysis detected with thromboelastography in a case of amniotic fluid embolism: fibrinolysis may precede coagulopathy M. FudabaD. TachibanaM. Koyama Report 29 July 2020 Pages: 818 - 820
Ultrastructure of a late-stage bacterial endocarditis valve vegetation Jean-Pierre BaudoinLaurence Camoin-JauNadji Hannachi BriefCommunication 04 August 2020 Pages: 821 - 826
Impact of COVID-19 on monitoring of therapeutic unfractionated heparin Sarah K. AdieNicholas Farina Report 19 August 2020 Pages: 827 - 829
Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis Mohamed Abdel-MaboudAmr MenshawyAhmed Negida Letter to the Editor 20 August 2020 Pages: 830 - 832
Correction to: The perplexity of catheter-directed thrombolysis for deep venous thrombosis: the approaches play an important role Cheng QianGuo-ping ChenYing-hao Li Correction 25 September 2020 Pages: 833 - 833